Luye Pharma Group (HK:2186) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Luye Pharma Group has issued an overseas regulatory announcement regarding the release of US$50 million 5.85% convertible bonds due in 2025. The company emphasizes that the information memorandum related to these bonds is not an invitation to the public to purchase or subscribe to securities. This move is aimed at ensuring equal information dissemination among investors in compliance with Hong Kong’s Listing Rules.
For further insights into HK:2186 stock, check out TipRanks’ Stock Analysis page.
